ADLAI NORTYE LTD-ADR (ANL:NASDAQ)
$11.94 0.64 (5.6637%)
Analysed ADLAI NORTYE LTD-ADR (ANL:NASDAQ) News Sources
Adlai Nortye Announces First Patient Enrolled in Global Phase 1 Trial of Pan-RAS (ON) Inhibitor AN9025 for Solid Tumors Harboring RAS Mutations
12-02-2026
yahoo.com
Adlai Nortye Ltd. Sponsored ADR (ANL) Upgraded to Buy: Here's Why
19-03-2026
yahoo.com
Is Astellas Pharma (ALPMY) Stock Outpacing Its Medical Peers This Year?
10-04-2026
yahoo.com
Adlai Nortye Announces $150.0 Million Private Placement Equity Financing
16-04-2026
yahoo.com
Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?
28-04-2026
yahoo.com
Adlai Nortye (ANL): 10 Tiny Stocks That Are On Fire Right Now
29-04-2026
yahoo.com
H.C. Wainwright Sees “Potential Best-in-Class Potency” for Adlai Nortye’s (ANL) Lead Asset, Lifts PT
01-05-2026
yahoo.com
Here's Why Adlai Nortye Ltd. Sponsored ADR (ANL) Is a Great 'Buy the Bottom' Stock Now
11-05-2026
yahoo.com
Are Medical Stocks Lagging ABCELLERA BIOLG (ABCL) This Year?
14-05-2026
yahoo.com
Adlai Nortye Ltd. Sponsored ADR (ANL) Upgraded to Buy: Here's What You Should Know
20-05-2026
yahoo.com
What is the current price of ADLAI NORTYE LTD-ADR (ANL:NASDAQ)?
The current price of ADLAI NORTYE LTD-ADR (ANL:NASDAQ) is $11.94.
ADLAI NORTYE LTD-ADR (ANL:NASDAQ) absolute price change since previous trading day?
The absolute price change of ADLAI NORTYE LTD-ADR (ANL:NASDAQ) since the previous trading day is $0.64.
ADLAI NORTYE LTD-ADR (ANL:NASDAQ) percentage price change since previous trading day?
The percentage price change of ADLAI NORTYE LTD-ADR (ANL:NASDAQ) since the previous trading day is 5.6637%.
What is the most recent average sentiment score for ADLAI NORTYE LTD-ADR (ANL:NASDAQ)?
The most recent average sentiment score for ADLAI NORTYE LTD-ADR (ANL:NASDAQ) is 57 out of 100.
What is the most recent average sentiment for ADLAI NORTYE LTD-ADR (ANL:NASDAQ)?
The most recent sentiment for ADLAI NORTYE LTD-ADR (ANL:NASDAQ) is .
SEC-8K** Filing Available For ADLAI NORTYE LTD-ADR (ANL:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.